Literature DB >> 15902688

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

Giovanna Roncador1, Philip J Brown, Lorena Maestre, Sophie Hue, Jorge L Martínez-Torrecuadrada, Khoon-Lin Ling, Sarah Pratap, Christy Toms, Bridget C Fox, Vincenzo Cerundolo, Fiona Powrie, Alison H Banham.   

Abstract

The transcription factor FOXP3 plays a key role in CD4(+)CD25(+) regulatory T cell function and represents a specific marker for these cells. Despite its strong association with regulatory T cell function, in humans little is known about the frequency of CD4(+)CD25(+) cells that express FOXP3 protein nor the distribution of these cells in vivo. Here we report the characterization of seven anti-FOXP3 monoclonal antibodies enabling the detection of endogenous human FOXP3 protein by flow cytometry and immunohistochemistry. Flow-cytometric analysis showed that FOXP3 was expressed by the majority of CD4(+)CD25(high) T cells in peripheral blood. By contrast, less than half of the CD4(+)CD25(int) population were FOXP3(+), providing an explanation for observations in human T cells that regulatory activity is enriched within the CD4(+)CD25(high) pool. Although FOXP3 expression was primarily restricted to CD4(+)CD25(+) cells, it was induced following activation of both CD4(+) and CD8(+) T cell clones. These findings indicate that the frequency of FOXP3(+) cells correlates with the level of expression of CD25 in naturally arising regulatory T cells and that FOXP3 protein is expressed by some activated CD4(+) and CD8(+) T cell clones. These reagents represent valuable research tools to further investigate FOXP3 function and are applicable for routine clinical use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902688     DOI: 10.1002/eji.200526189

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  176 in total

Review 1.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

2.  Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood T cells in children born to mothers with type 1 diabetes.

Authors:  B C Holm; J Svensson; C Akesson; J Arvastsson; J Ljungberg; K Lynch; S-A Ivarsson; A Lernmark; C M Cilio
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

3.  FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Kathryn Bembas; Ran Tao; Samik Basu; James L Riley; Wayne W Hancock; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

4.  Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.

Authors:  Dat Q Tran; Heather Ramsey; Ethan M Shevach
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

5.  Expression pattern of XBP1(S) in human B-cell lymphomas.

Authors:  Lorena Maestre; Reuben Tooze; Marta Cañamero; Santiago Montes-Moreno; Rocio Ramos; Gina Doody; May Boll; Sharon Barrans; Sara Baena; Miguel Angel Piris; Giovanna Roncador
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

6.  Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action.

Authors:  H H Olsen; V Muratov; K Cederlund; J Lundahl; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 7.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis.

Authors:  Vladislaw Muratov; Ann-Kristin Ulfgren; Marianne Engström; Kerstin Elvin; Ola Winqvist; Robert Löfberg; Joachim Lundahl
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

9.  CD25high T cells with a prolonged survival inhibit development of diabetes.

Authors:  Y Yan; Z Xiong; S Zhang; J Song; Y Huang; A M Thornton; H Wang; X-F Yang
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Oct-Dec       Impact factor: 3.219

10.  Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood.

Authors:  Fang Hua; Ning Kang; Yun-An Gao; Lian-Xian Cui; De-Nian Ba; Wei He
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.